Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5NET 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Colorectal Neoplasms 47Pancreatic Neoplasms 43Neoplasm Metastasis 20Carcinoma, Hepatocellular 20Lung Neoplasms 15Ovarian Neoplasms 14Colonic Neoplasms 14Rectal Neoplasms 12Stomach Neoplasms 11Prostatic Neoplasms 11Melanoma 11Cholangiocarcinoma 11Carcinoma, Renal Cell 10Breast Neoplasms 10Sarcoma 8Lymphoma, Non-Hodgkin 8Glioma 8Carcinoma, Non-Small-Cell Lung 8Neuroblastoma 7Hepatoblastoma 7Esophageal Neoplasms 7Barrett Esophagus 7Anus Neoplasms 7Wilms Tumor 6Uterine Cervical Neoplasms 6Medulloblastoma 6Gastrointestinal Neoplasms 6Ependymoma 6Central Nervous System Neoplasms 6Adenocarcinoma Of Esophagus 6

Interventions

pembrolizumab 3spartalizumab 2trametinib 1tislelizumab 1palbociclib 1nazartinib 1milademetan 1enzalutamide 1devimistat 1dehydroftorafur 1canakinumab 1binimetinib 1bemarituzumab 1aldesleukin 1Specimen Handling 1Pentostatin 1Midazolam 1Methods 1Magnetic Resonance Spectroscopy 1Letrozole 1Interleukin-2 1IFL protocol 1Hydroxychloroquine 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Early Intervention, Educational 1Cyclophosphamide 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Specimen Handling × Gastrointestinal × Clear all
NCT05733000 2023-03-10

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Northwestern University

Phase 2 Recruiting
94 enrolled
GastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma of Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡